Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Siwen Hu‐Lieskovan | Researchclopedia

Back to researchers

Siwen Hu‐Lieskovan

University of Utah ORCID

291

Works

24,685

Citations

48

h-index

73

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Immunotherapy and Immune Responses

Affiliations

Goethe University Frankfurt2011–2011

University of Southern California2005–2011

California Institute of Technology2005–2005

APLA Health2017–2019

Children's Hospital of Los Angeles2005–2007

Top Works

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Padmanee Sharma,Siwen Hu‐Lieskovan,et al.

20175,292 citations

Immune Cell Function and Interaction

Lung Cancer Treatments and Mutations

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Willy Hugo,Jesse M. Zaretsky,et al.

20163,497 citations

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

Jesse M. Zaretsky,Ángel García-Díaz,et al.

20163,101 citations

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Ángel García-Díaz,Daniel Sanghoon Shin,et al.

20171,866 citations

Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations

Daniel Sanghoon Shin,Jesse M. Zaretsky,et al.

20161,263 citations

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Sapna P. Patel,Megan Othus,et al.

2023767 citations

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Patrick A. Ott,Siwen Hu‐Lieskovan,et al.

2020717 citations

Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?

Charlene M. Fares,Eliezer M. Van Allen,et al.

2019635 citations

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanoma

Siwen Hu‐Lieskovan,Stephen Mok,et al.

2015565 citations